Zoll revenue, income slip for Q4, year-end results

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Zoll Medical, a manufacturer of resuscitation devices and software solutions, has reported fiscal 2009 revenues of $385.2 million, a decline of 3 percent compared to fiscal 2008 revenues of $398 million.

According to the Chelmsford, Mass.-based company, the revenue results reflected a negative foreign exchange impact of nearly $12 million compared to fiscal 2008. The results include approximately $6.9 million of revenue derived from its new temperature management business, whose assets were acquired from Alsius in May.

The 2009 net income for the year was $9.6 million, compared to $23.4 million in the prior year, Zoll stated.

The company reported that its annual sales to the North American market decreased 5 percent to $287.6 million, compared to $301.4 million in 2008. Also, sales to the North American hospital market decreased 20 percent to $93.3 million, compared to $117.1 million last year. Sales to the North American pre-hospital market increased 6 percent to $171.2 million, compared to $161.7 million in the prior year, while International revenues increased by 1 percent to $97.6 million, compared to $96.6 million last year.

According to the company, LifeVest revenues increased 66 percent to $43.9 million, compared to $26.5 million last year. Total AutoPulse sales decreased 6 percent to $16.7 million for the year, compared to $17.8 million in the prior year.

Zoll reported that fourth quarter revenues for fiscal year 2009 increased 2 percent to $107.9 million, compared to $105.6 million in the fourth quarter of last year. Revenue results reflected a negative foreign exchange impact of approximately $1.4 million compared to the fourth quarter of fiscal 2008. The fourth quarter results include approximately $5 million of revenue derived from the company’s newly acquired temperature management business.

Net income decreased 62 percent to $3.4 million, compared to $8.9 million in the prior-year period, the company reported.

The fourth quarter sales to the North American market decreased 2 percent to $79.1 million, compared to $81.1 million in the fourth quarter of 2008, according to the company. Sales to the North American hospital market decreased 3 percent to $28.9 million, compared to $29.7 million in the fourth quarter of last year. Sales to the North American pre-hospital market decreased 2 percent to $44.5 million, compared to $45.6 million for the same period last year. International sales increased by 17 percent to $28.8 million, compared to $24.5 million in the fourth quarter last year.

Zoll said that the LifeVest revenues increased 59 percent to $12.9 million as compared to $8.1 million in the prior-year quarter. Total AutoPulse shipments to all markets decreased by 41 percent to $4.1 million, compared to $7 million in the fourth quarter of 2008.